Pulmonx (LUNG) Cash from Investing Activities (2019 - 2025)

Pulmonx (LUNG) has reported Cash from Investing Activities for 7 consecutive years, with $8.7 million the latest figure, recorded in Q3 2025.

• In Q3 2025, Cash from Investing Activities rose 29.03% year-over-year to $8.7 million; the TTM figure through Sep 2025 stood at $44.6 million (up 6713.76% YoY), while the FY2024 annual figure was $17.5 million, up 970.75% from the prior year.
• Cash from Investing Activities grew to $8.7 million in Q3 2025 per LUNG's latest filing, from $5.5 million in the prior quarter.
• Across five years, Cash from Investing Activities topped out at $16.3 million in Q1 2025 and bottomed at -$29.1 million in Q4 2021.
• Historically, Cash from Investing Activities has averaged -$237684.2 across 5 years, with a median of -$727000.0 in 2022.
• Annual changes were most pronounced in 2021 — Cash from Investing Activities tumbled 4392.11% — and 2023, when it soared 2143.18%.
• Pulmonx's Cash from Investing Activities stood at -$29.1 million in 2021, then surged by 97.5% to -$727000.0 in 2022, then sank by 278.95% to -$2.8 million in 2023, then jumped by 610.6% to $14.1 million in 2024, then slumped by 38.07% to $8.7 million in 2025.
• Business Quant data shows LUNG's Cash from Investing Activities at $8.7 million in Q3 2025, $5.5 million in Q2 2025, and $16.3 million in Q1 2025.